150 related articles for article (PubMed ID: 31161818)
1.
Liu F; Zou Y; Wang F; Yang B; Zhang Z; Luo Y; Liang M; Zhou J; Huang O
Genet Test Mol Biomarkers; 2019 Jun; 23(6):409-417. PubMed ID: 31161818
[No Abstract] [Full Text] [Related]
2. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
[TBL] [Abstract][Full Text] [Related]
3. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
Zhang J; Zhou M; Zhao X; Wang G; Li J
Pathol Res Pract; 2020 Aug; 216(8):152994. PubMed ID: 32402537
[TBL] [Abstract][Full Text] [Related]
5. TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis.
Zhang G; Zhu Q; Fu G; Hou J; Hu X; Cao J; Peng W; Wang X; Chen F; Cui H
Br J Cancer; 2019 Dec; 121(12):1069-1078. PubMed ID: 31740732
[TBL] [Abstract][Full Text] [Related]
6. miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.
Gong L; Ren M; Lv Z; Yang Y; Wang Z
DNA Cell Biol; 2018 May; 37(5):501-511. PubMed ID: 29638162
[TBL] [Abstract][Full Text] [Related]
7. FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells.
Bi Y; Yang Y; Zhang Y; Cheng C; Tang P; Xiao H; Yuan F; Wu W; Yang B
Neoplasma; 2023 Dec; 70(6):733-746. PubMed ID: 38014700
[TBL] [Abstract][Full Text] [Related]
8. Landscape of genomic alterations in cervical carcinomas.
Ojesina AI; Lichtenstein L; Freeman SS; Pedamallu CS; Imaz-Rosshandler I; Pugh TJ; Cherniack AD; Ambrogio L; Cibulskis K; Bertelsen B; Romero-Cordoba S; Treviño V; Vazquez-Santillan K; Guadarrama AS; Wright AA; Rosenberg MW; Duke F; Kaplan B; Wang R; Nickerson E; Walline HM; Lawrence MS; Stewart C; Carter SL; McKenna A; Rodriguez-Sanchez IP; Espinosa-Castilla M; Woie K; Bjorge L; Wik E; Halle MK; Hoivik EA; Krakstad C; Gabiño NB; Gómez-Macías GS; Valdez-Chapa LD; Garza-Rodríguez ML; Maytorena G; Vazquez J; Rodea C; Cravioto A; Cortes ML; Greulich H; Crum CP; Neuberg DS; Hidalgo-Miranda A; Escareno CR; Akslen LA; Carey TE; Vintermyr OK; Gabriel SB; Barrera-Saldaña HA; Melendez-Zajgla J; Getz G; Salvesen HB; Meyerson M
Nature; 2014 Feb; 506(7488):371-5. PubMed ID: 24390348
[TBL] [Abstract][Full Text] [Related]
9. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F
FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255
[TBL] [Abstract][Full Text] [Related]
10. Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
Xu Y; Yu J; Liu T; Meng F; Kong D; Lou G
Biomarkers; 2016; 21(4):379-85. PubMed ID: 26954701
[TBL] [Abstract][Full Text] [Related]
11. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
Lu H; Yao B; Wen X; Jia B
BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of FBXW7 mutation in serous endometrial cancer: Increased levels of potentially druggable proteins and sensitivity to SI-2 and dinaciclib.
Urick ME; Bell DW
Mol Carcinog; 2018 Nov; 57(11):1445-1457. PubMed ID: 29963728
[TBL] [Abstract][Full Text] [Related]
13. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
Xiang J; Hang JB; Che JM; Li HC
Int J Clin Exp Pathol; 2015; 8(8):9147-53. PubMed ID: 26464659
[TBL] [Abstract][Full Text] [Related]
14. Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma.
Zheng Y; Song A; Wang C; Zhang W; Liang D; Ding X; Li G; Zhang H; Zhang W; Du Y; Zhou J; Wu H; Wu Y; Song X
Cell Death Dis; 2020 Aug; 11(8):615. PubMed ID: 32792479
[TBL] [Abstract][Full Text] [Related]
15. The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.
Koga Y; Iwatsuki M; Yamashita K; Kiyozumi Y; Kurashige J; Masuda T; Eto K; Iwagami S; Harada K; Ishimoto T; Baba Y; Yoshida N; Miyanari N; Takamori H; Ajani JA; Baba H
Gastric Cancer; 2019 Nov; 22(6):1100-1108. PubMed ID: 30854619
[TBL] [Abstract][Full Text] [Related]
16. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
Zhang MX; Wang H; Sun GP
Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
[TBL] [Abstract][Full Text] [Related]
17. MiR-223 promotes oral squamous cell carcinoma proliferation and migration by regulating FBXW7.
Jiang L; Lv L; Liu X; Jiang X; Yin Q; Hao Y; Xiao L
Cancer Biomark; 2019; 24(3):325-334. PubMed ID: 30883339
[TBL] [Abstract][Full Text] [Related]
18. miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.
Zhou C; Shen L; Mao L; Wang B; Li Y; Yu H
Biochem Biophys Res Commun; 2015 Feb; 458(1):63-9. PubMed ID: 25623537
[TBL] [Abstract][Full Text] [Related]
19. The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function.
Ren L; Yang J; Meng X; Zhang J; Zhang Y
Hum Cell; 2022 Mar; 35(2):472-485. PubMed ID: 35094292
[TBL] [Abstract][Full Text] [Related]
20. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]